LPTX

Leap Therapeutics (LPTX)

Leap Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LPTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/24	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LPTX	Leap Therapeutics Inc
2024/05/24	05:25	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:LPTX	Leap Therapeutics Inc
2024/05/13	20:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LPTX	Leap Therapeutics Inc
2024/05/13	20:00	PR Newswire (US)	Leap Therapeutics Reports First Quarter 2024 Financial Results	NASDAQ:LPTX	Leap Therapeutics Inc
2024/05/13	19:50	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LPTX	Leap Therapeutics Inc
2024/05/11	06:01	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:LPTX	Leap Therapeutics Inc
2024/05/10	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LPTX	Leap Therapeutics Inc
2024/04/11	21:30	PR Newswire (US)	Leap Therapeutics Announces $40 Million Private Placement	NASDAQ:LPTX	Leap Therapeutics Inc
2024/03/18	20:00	PR Newswire (US)	Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:LPTX	Leap Therapeutics Inc
2024/02/01	11:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LPTX	Leap Therapeutics Inc
2024/02/01	11:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LPTX	Leap Therapeutics Inc
2024/02/01	11:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LPTX	Leap Therapeutics Inc
2024/02/01	11:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LPTX	Leap Therapeutics Inc
2024/02/01	11:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LPTX	Leap Therapeutics Inc
2024/02/01	11:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LPTX	Leap Therapeutics Inc
2024/02/01	11:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LPTX	Leap Therapeutics Inc
2024/02/01	11:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LPTX	Leap Therapeutics Inc
2024/01/31	10:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LPTX	Leap Therapeutics Inc
2024/01/31	10:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LPTX	Leap Therapeutics Inc
2024/01/27	07:21	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:LPTX	Leap Therapeutics Inc
2024/01/24	07:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LPTX	Leap Therapeutics Inc
2024/01/17	07:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LPTX	Leap Therapeutics Inc
2024/01/17	07:05	PR Newswire (US)	Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium	NASDAQ:LPTX	Leap Therapeutics Inc
2024/01/03	21:00	PR Newswire (US)	Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:LPTX	Leap Therapeutics Inc
2024/01/02	21:00	PR Newswire (US)	Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients	NASDAQ:LPTX	Leap Therapeutics Inc
2023/12/13	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LPTX	Leap Therapeutics Inc
2023/12/12	06:05	PR Newswire (US)	Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium	NASDAQ:LPTX	Leap Therapeutics Inc
2023/11/21	21:00	PR Newswire (US)	Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference	NASDAQ:LPTX	Leap Therapeutics Inc
2023/11/13	21:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LPTX	Leap Therapeutics Inc
2023/11/13	21:00	PR Newswire (US)	Leap Therapeutics Reports Third Quarter 2023 Financial Results	NASDAQ:LPTX	Leap Therapeutics Inc